기준가
$67.09
운용 규모
$352.9M
보수율
-
배당수익률
0.37%
베타
0.79
통화
USD
| YTD | 1개월 | 3개월 | 1년 | 3년 | 5년 |
|---|---|---|---|---|---|
| +19.91% | +17.74% | +23.57% | +62.69% | +19.17% | +6.45% |
| 순위 | 종목코드 | 종목명 | 비중 |
|---|---|---|---|
| 1 | OGN | Organon & Co Ordinary Shares | 3.78% |
| 2 | CORT | Corcept Therapeutics Inc | 3.74% |
| 3 | LQDA | Liquidia Corp Ordinary Shares | 2.91% |
| 4 | AXSM | Axsome Therapeutics Inc | 2.67% |
| 5 | DFTX | Definium Therapeutics Inc Ordinary Shares | 2.35% |
| 6 | ELVN | Enliven Therapeutics Inc | 2.34% |
| 7 | JAZZ | Jazz Pharmaceuticals PLC | 2.31% |
| 8 | RPRX | Royalty Pharma PLC Class A | 2.17% |
| 9 | TRVI | Trevi Therapeutics Inc | 2.15% |
| 10 | VTRS | Viatris Inc | 2.11% |
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
설정일: 2006-06-19